RPTN
geneOn this page
Also known as FLJ39117
Summary
RPTN (repetin, HGNC:26809) is a protein-coding gene on chromosome 1q21.3, encoding Repetin (Q6XPR3). Involved in the cornified cell envelope formation.
Predicted to enable calcium ion binding activity and transition metal ion binding activity. Predicted to be located in cytosol. Predicted to be active in cornified envelope.
Source: NCBI Gene 126638 — RefSeq curated summary.
At a glance
- GWAS associations: 18
- Clinical variants (ClinVar): 111 total
- MANE Select transcript:
NM_001122965
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26809 |
| Approved symbol | RPTN |
| Name | repetin |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ39117 |
| Ensembl gene | ENSG00000215853 |
| Ensembl biotype | protein_coding |
| OMIM | 613259 |
| Entrez | 126638 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000316073
RefSeq mRNA: 1 — MANE Select: NM_001122965
NM_001122965
CCDS: CCDS41397
Canonical transcript exons
ENST00000316073 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001235715 | 152153595 | 152156960 |
| ENSE00001447991 | 152157752 | 152157909 |
| ENSE00001447992 | 152159184 | 152159228 |
Expression profiles
Bgee: expression breadth broad, 57 present calls, max score 87.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1745 / max 107.2182, expressed in 31 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14536 | 0.1745 | 31 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gingiva | UBERON:0001828 | 87.89 | gold quality |
| gingival epithelium | UBERON:0001949 | 84.31 | gold quality |
| tongue | UBERON:0001723 | 78.36 | gold quality |
| body of tongue | UBERON:0011876 | 74.97 | gold quality |
| superior surface of tongue | UBERON:0007371 | 74.75 | gold quality |
| skin of leg | UBERON:0001511 | 73.59 | gold quality |
| sperm | CL:0000019 | 72.53 | silver quality |
| amniotic fluid | UBERON:0000173 | 72.39 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 72.33 | gold quality |
| zone of skin | UBERON:0000014 | 71.37 | gold quality |
| skin of hip | UBERON:0001554 | 71.10 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 68.68 | silver quality |
| skin of abdomen | UBERON:0001416 | 68.21 | gold quality |
| oral cavity | UBERON:0000167 | 66.72 | gold quality |
| tonsil | UBERON:0002372 | 65.68 | gold quality |
| upper leg skin | UBERON:0004262 | 64.62 | gold quality |
| mammalian vulva | UBERON:0000997 | 61.14 | silver quality |
| penis | UBERON:0000989 | 60.31 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 53.54 | gold quality |
| vagina | UBERON:0000996 | 52.27 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 50.81 | silver quality |
| ectocervix | UBERON:0012249 | 50.68 | gold quality |
| esophagus mucosa | UBERON:0002469 | 48.67 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 45.83 | gold quality |
| uterine cervix | UBERON:0000002 | 45.26 | gold quality |
| islet of Langerhans | UBERON:0000006 | 44.57 | gold quality |
| lower lobe of lung | UBERON:0008949 | 43.44 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 42.72 | silver quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.27 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
69 targeting RPTN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-4756-3P | 99.62 | 66.30 | 1319 |
| HSA-MIR-7844-5P | 99.55 | 68.56 | 1428 |
| HSA-MIR-4273 | 99.45 | 67.93 | 1206 |
| HSA-MIR-6165 | 99.44 | 67.12 | 1389 |
| HSA-MIR-3911 | 99.38 | 66.95 | 1087 |
| HSA-MIR-12113 | 99.32 | 67.54 | 1072 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-877-3P | 99.09 | 68.10 | 1637 |
| HSA-MIR-4711-3P | 98.97 | 66.87 | 1020 |
| HSA-MIR-6760-5P | 98.87 | 66.73 | 1515 |
Literature-anchored findings (GeneRIF, showing 3)
- RPTN plays a potential role in emotional and cognitive processing; its decrease in serum may indicate its involvement in the pathogenesis of schizophrenia and bipolar disorder (PMID:25613293)
- The single-nucleotide polymorphisms of CRNN (rs941934) and RPTN (rs3001978, rs28441202) may contribute to Atopic Dermatitis development, but further studies on a larger group of Atopic Dermatitis patients are needed to verify this assumption. (PMID:28219068)
- Letter: RPTN gene is associated with straight hair in Europeans and East Asians. Genetics of straight hair may to some degree overlap between these two ancestry groups. (PMID:29935789)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rptn | ENSMUSG00000041984 |
| rattus_norvegicus | Rptn | ENSRNOG00000018679 |
Paralogs (3): FLG2 (ENSG00000143520), FLG (ENSG00000143631), HRNR (ENSG00000197915)
Protein
Protein identifiers
Repetin — Q6XPR3 (reviewed: Q6XPR3)
All UniProt accessions (1): Q6XPR3
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the cornified cell envelope formation. Multifunctional epidermal matrix protein. Reversibly binds calcium.
Subcellular location. Secreted. Extracellular space. Extracellular matrix.
Tissue specificity. Expression is scattered in the normal epidermis but strong in the acrosyringium, the inner hair root sheath and in the filiform papilli of the tongue.
Post-translational modifications. Potential substrate of transglutaminase. Some arginines are probably converted to citrullines by peptidylarginine deimidase.
Domain organisation. Can be divided into a N-terminal domain with significant homology to S100-like calcium-binding proteins, a central domain containing a series of short tandem repeats, and two flanking segments with low homology to the consensus sequences of the central repeats.
Similarity. Belongs to the S100-fused protein family.
RefSeq proteins (1): NP_001116437* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001751 | S100/CaBP7/8-like_CS | Conserved_site |
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR013787 | S100_Ca-bd_sub | Domain |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
| IPR034325 | S-100_dom | Domain |
Pfam: PF01023
UniProt features (25 total): compositionally biased region 10, binding site 6, region of interest 5, domain 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6XPR3-F1 | 42.63 | 0.02 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (6): 32; 62; 64; 66; 68; 73
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-6805567 | Keratinization |
MSigDB gene sets: 72 (showing top):
DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_UP, DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP, MARTINEZ_RB1_TARGETS_UP, MARTINEZ_RB1_AND_TP53_TARGETS_UP, chr1q21, GOCC_CORNIFIED_ENVELOPE, DODD_NASOPHARYNGEAL_CARCINOMA_DN, RICKMAN_HEAD_AND_NECK_CANCER_E, MARTENS_TRETINOIN_RESPONSE_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, REACTOME_KERATINIZATION, REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE
GO Biological Process (0):
GO Molecular Function (3): calcium ion binding (GO:0005509), transition metal ion binding (GO:0046914), metal ion binding (GO:0046872)
GO Cellular Component (3): cornified envelope (GO:0001533), cytosol (GO:0005829), extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Keratinization | 1 |
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metal ion binding | 2 |
| cellular anatomical structure | 2 |
| cation binding | 1 |
| plasma membrane | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
1403 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RPTN | DEPP1 | Q9NTK1 | 936 |
| RPTN | LCE3C | Q5T5A8 | 658 |
| RPTN | LORICRIN | P23490 | 608 |
| RPTN | TCHH | Q07283 | 604 |
| RPTN | LCE3B | Q5TA77 | 590 |
| RPTN | S100Z | Q8WXG8 | 571 |
| RPTN | LCE5A | Q5TCM9 | 518 |
| RPTN | FLG | P20930 | 515 |
| RPTN | LCE3A | Q5TA76 | 511 |
| RPTN | IVL | P07476 | 510 |
| RPTN | SPRR2A | P35326 | 483 |
| RPTN | SPRR4 | Q96PI1 | 474 |
| RPTN | LCE1C | Q5T751 | 442 |
| RPTN | CRNN | Q9UBG3 | 437 |
| RPTN | OR51Q1 | Q8NH59 | 434 |
| RPTN | LCE3E | Q5T5B0 | 434 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| MAP1LC3B | psi-mi:“MI:0914”(association) | 0.350 | |
| GABARAPL2 | psi-mi:“MI:0914”(association) | 0.350 | |
| GABARAPL1 | psi-mi:“MI:0914”(association) | 0.350 | |
| FNDC5 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): RPTN (Affinity Capture-MS), RPTN (Affinity Capture-MS), RPTN (Affinity Capture-MS), RPTN (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUL8, A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A6NJ88, A6QL64, B4DH59, D3ZVV1, E9Q6E9, F1LWT0, O04492, O88799, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18583, P53353, Q08AG5, Q0P6D6, Q2EG98, Q3BBV2, Q4ZJZ1, Q5HY64, Q5JPF3, Q5QGU6, Q5TAG4, Q5TI25, Q5XHX6, Q6P3W6, Q6P902, Q6XPR3, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8N2N9, Q8N660, Q8N693, Q96EQ9
Diamond homologs: A6QP92, P20930, P37709, P97347, Q07283, Q2VIS4, Q5D862, Q5QJ38, Q6XPR3, Q9D3P1, Q9UBG3, A7K6Y8, A7K6Y9, O77691, O77791, P02632, P02633, P02634, P02638, P02639, P04271, P04631, P05109, P05942, P05943, P05964, P06702, P06703, P07091, P14069, P22793, P23297, P24479, P24480, P25815, P27004, P27005, P28318, P28782, P28783
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
111 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 94 |
| Likely benign | 16 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
150 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:152156956:GGTCT:G | acceptor_gain | 1.0000 |
| 1:152156957:GTCT:G | acceptor_gain | 1.0000 |
| 1:152156958:TCT:T | acceptor_gain | 1.0000 |
| 1:152156959:CT:C | acceptor_gain | 1.0000 |
| 1:152156959:CTC:C | acceptor_gain | 1.0000 |
| 1:152156960:TCT:T | acceptor_gain | 1.0000 |
| 1:152156961:C:A | acceptor_loss | 1.0000 |
| 1:152156961:C:CC | acceptor_gain | 1.0000 |
| 1:152157746:TCTTA:T | donor_loss | 1.0000 |
| 1:152157747:CTTA:C | donor_loss | 1.0000 |
| 1:152157748:TTAC:T | donor_loss | 1.0000 |
| 1:152157749:TA:T | donor_loss | 1.0000 |
| 1:152157751:C:CT | donor_loss | 1.0000 |
| 1:152157905:TGAAC:T | acceptor_gain | 1.0000 |
| 1:152157907:AAC:A | acceptor_gain | 1.0000 |
| 1:152157908:AC:A | acceptor_gain | 1.0000 |
| 1:152157909:CC:C | acceptor_gain | 1.0000 |
| 1:152157910:C:CC | acceptor_gain | 1.0000 |
| 1:152157910:CT:C | acceptor_loss | 1.0000 |
| 1:152156961:C:G | acceptor_gain | 0.9900 |
| 1:152156964:T:C | acceptor_gain | 0.9900 |
| 1:152156964:T:TC | acceptor_gain | 0.9900 |
| 1:152157750:A:AC | donor_gain | 0.9900 |
| 1:152157751:C:CC | donor_gain | 0.9900 |
| 1:152157906:GAAC:G | acceptor_gain | 0.9900 |
| 1:152159178:TCTTA:T | donor_loss | 0.9900 |
| 1:152159179:CTTA:C | donor_loss | 0.9900 |
| 1:152159180:TTACC:T | donor_loss | 0.9900 |
| 1:152159181:TAC:T | donor_loss | 0.9900 |
| 1:152159183:C:CG | donor_loss | 0.9900 |
AlphaMissense
5315 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:152157845:G:C | F15L | 0.985 |
| 1:152157845:G:T | F15L | 0.985 |
| 1:152157847:A:G | F15L | 0.985 |
| 1:152156886:A:C | F71L | 0.975 |
| 1:152156886:A:T | F71L | 0.975 |
| 1:152156888:A:G | F71L | 0.975 |
| 1:152156862:G:C | F79L | 0.967 |
| 1:152156862:G:T | F79L | 0.967 |
| 1:152156864:A:G | F79L | 0.967 |
| 1:152157783:A:G | L36P | 0.965 |
| 1:152156879:A:C | Y74D | 0.964 |
| 1:152156879:A:G | Y74H | 0.964 |
| 1:152156878:T:G | Y74S | 0.963 |
| 1:152157792:A:G | L33S | 0.955 |
| 1:152156887:A:G | F71S | 0.952 |
| 1:152156875:A:G | L75P | 0.951 |
| 1:152156849:C:G | A84P | 0.949 |
| 1:152157780:A:G | L37P | 0.949 |
| 1:152157846:A:G | F15S | 0.944 |
| 1:152156857:A:G | L81S | 0.940 |
| 1:152156917:A:G | L61S | 0.934 |
| 1:152157767:A:C | F41L | 0.933 |
| 1:152157767:A:T | F41L | 0.933 |
| 1:152157769:A:G | F41L | 0.933 |
| 1:152157867:A:T | I8K | 0.933 |
| 1:152157788:T:A | K34N | 0.930 |
| 1:152157788:T:G | K34N | 0.930 |
| 1:152156879:A:T | Y74N | 0.929 |
| 1:152157780:A:T | L37H | 0.929 |
| 1:152157756:A:G | L45P | 0.925 |
dbSNP variants (sampled 300 via entrez): RS1000437682 (1:152159010 A>T), RS1000477799 (1:152155338 C>G), RS1001343280 (1:152156412 A>G), RS1002242149 (1:152157014 G>A,T), RS1003780838 (1:152158141 A>G), RS1003957986 (1:152159487 T>C), RS1004687003 (1:152154662 C>T), RS1004984886 (1:152159308 G>A), RS1005967736 (1:152160209 T>C), RS1006198385 (1:152158242 C>G,T), RS1006539203 (1:152154270 C>T), RS1006865090 (1:152154985 G>T), RS1007309974 (1:152155001 C>T), RS1007645567 (1:152160965 A>G), RS1008045936 (1:152160487 G>A)
Disease associations
OMIM: gene MIM:613259 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
18 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004861_28 | Itch intensity from mosquito bite | 3.000000e-08 |
| GCST005038_8 | Allergic disease (asthma, hay fever or eczema) | 7.000000e-17 |
| GCST006661_183 | Male-pattern baldness | 1.000000e-10 |
| GCST007563_33 | Allergic disease (asthma, hay fever or eczema) | 3.000000e-11 |
| GCST007564_24 | Asthma or allergic disease (pleiotropy) | 5.000000e-12 |
| GCST007797_16 | Asthma onset (childhood vs adult) | 8.000000e-24 |
| GCST007798_7 | Asthma | 4.000000e-24 |
| GCST007800_52 | Asthma (childhood onset) | 8.000000e-48 |
| GCST008916_82 | Asthma | 5.000000e-27 |
| GCST008916_88 | Asthma | 1.000000e-25 |
| GCST009798_26 | Asthma | 2.000000e-21 |
| GCST009798_76 | Asthma | 1.000000e-22 |
| GCST010984_48 | Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis) | 6.000000e-19 |
| GCST010985_2 | Allergic disease (asthma, hay fever and/or eczema) (age of onset) | 3.000000e-48 |
| GCST011053_6 | Neuroblastoma (pediatric) | 8.000000e-23 |
| GCST011379_1 | Cutaneous mastocytosis (childhood) | 4.000000e-09 |
| GCST011381_4 | Cutaneous mastocytosis | 3.000000e-11 |
| GCST011383_4 | Mastocytosis | 8.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
| EFO:0004847 | age at onset |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression, affects expression, decreases reaction | 3 |
| hydroquinone | increases expression | 2 |
| Sodium Dodecyl Sulfate | decreases expression, increases expression | 2 |
| Tetrachlorodibenzodioxin | increases expression | 2 |
| urushiol | increases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| trichostatin A | affects expression, decreases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Antimony Potassium Tartrate | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Coal Tar | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cutaneous mastocytosis, mastocytosis, neuroblastoma